Fuad El Rassi, MD

Role

Hematology
Specialty

Blood Disorders
Research Program

Discovery and Developmental Therapeutics
Practicing Since

2014

Call 404-778-1900

Background

Fuad El Rassi, MD, a board-certified hematologist, treats patients with sickle cell anemia and other blood disorders. He leads the sickle cell research program at Grady Health System, where investigational agents and curative treatments are being evaluated in phase I, II and III clinical trials. He also treats patients with benign hematologic conditions at Emory University Hospital Midtown.

Dr. El Rassi is an associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine and serves as chief of hematology for Emory at Grady.

He is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute. He serves on the board and as treasurer for the Sickle Cell Adult Provider Network. He is also involved in training hematology and medical oncology fellows in benign hematology and chairs the Fellowship Competency Committee.

Dr. El Rassi earned his medical degree from the American University of Beirut in Beirut, Lebanon. His postgraduate training included a residency in internal medicine at Saint Louis University Hospital and a fellowship in hematology and medical oncology at Winship Cancer Institute of Emory University.

Titles & Roles

Associate Professor, Department of Hematology and Medical Oncology

Emory University School of Medicine
Chief of Hematology

Emory at Grady
Director of Sickle Cell Research, Georgia Comprehensive Sickle Cell Program

Grady Health System

Education & Training

Education

Fellowship, Hematology & Oncology, 2014
Emory University School of Medicine
Residency, Internal Medicine, 2011
Saint Louis University School of Medicine
Medical Education, MD, 2006
American Univeristy of Beirut

Board Certifications

Hematology
American Board of Internal Medicine, 2014
Internal Medicine
American Board of Internal Medicine, 2011

Professional Memberships

American Society of Hematology
Sickle Cell Adult Provider Network
Sickle Cell Disease Foundation Research
American Society of Clinical Oncology

Research

Publications

Title/Journal	Authors	Publication Date
The ASH Research Collaborative Sickle Cell Disease Research Network: Past, Present and Future. Blood advances	F El Rassi, B Andemariam, A Kutlar, BS Pace, A Fink, K Torres, C Dowd, CS Abrams	09/03/2025
The Mortality of Adults With Sickle Cell Disease at a Comprehensive Sickle Cell Center. European journal of haematology	JA Afranie-Sakyi, E Randall, R Fasano, ML McLemore, F El Rassi	04/01/2025
Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease. Blood advances	MC Walters, M Eapen, Y Liu, F El Rassi, EK Waller, JE Levine, JJ Strouse, JH Antin, SH Parikh, N Bakshi, C Dampier, JJ Jaroscak, S Bergmann, T Wong, V Kota, B Pace, LJ Lekakis, P Lulla, RS Nickel, KA Kasow, U Popat, W Smith, L Yu, N DiFronzo, N Geller, N Kamani, ES Klings, K Hassell, A Mendizabal, K Sullivan, D Neuberg, L Krishnamurti	03/11/2025
Long-term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A STELLAR interim analysis. American journal of hematology	SD Arnold, N Bakshi, D Ross, C Smith, C Sinha, A Veludhandi, V Dutreuil, S Bai, LR Meacham, G Guilcher, M Bhatia, A Abraham, KA Kasow, A Haight, F El Rassi, E Stenger, J Lipscomb, L Krishnamurti	10/01/2024
Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial. The Lancet. Haematology	MT Gladwin, VR Gordeuk, PC Desai, C Minniti, EM Novelli, CR Morris, KI Ataga, L De Castro, SA Curtis, F El Rassi, HJ Ford, T Harrington, ES Klings, S Lanzkron, D Liles, J Little, A Nero, W Smith, JG Taylor, A Baptiste, W Hagar, J Kanter, A Kinzie, T Martin, A Rafique, MJ Telen, CM Lalama, GJ Kato, KZ Abebe	05/01/2024
Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease. British journal of haematology	H Nakahara, N Cheedarla, HP Verkerke, S Cheedarla, SC Wu, JE Hendrickson, A Chang, ML McLemore, F El Rassi, JD Roback, AS Neish, RM Fasano, SR Stowell	09/01/2023
Presentations and outcomes among sickle cell disease patients with COVID-19 at a large southern healthcare system. Expert review of hematology	K Clarke, YM Shin, MAK Hall, M Moussa, M McLemore, F El Rassi	02/01/2023
A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis. Blood	CD Dampier, MJ Telen, T Wun, RC Brown, P Desai, F El Rassi, B Fuh, J Kanter, Y Pastore, J Rothman, JG Taylor, D Readett, KM Sivamurthy, B Tammara, LJ Tseng, JN Lozier, H Thackray, JL Magnani, KL Hassell	01/12/2023
Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high- and low- to middle-income countries for the international Sickle Cell World Assessment Survey. American journal of hematology	I Osunkwo, J James, F El-Rassi, A Nero, CP Minniti, C Trimnell, J Paulose, N Ramscar, T Bailey, O Rajkovic-Hooley, B Andemariam	08/01/2022
Sickle Cell Disease and Kidney. Advances in chronic kidney disease	P Amarapurkar, L Roberts, J Navarrete, F El Rassi	03/01/2022
Catastrophic Neurological Complications in 2 Patients With Sickle Cell Disease and COVID-19. Journal of investigative medicine high impact case reports	K Clarke, K Benameur, Z Wiley, YM Shin, M Moussa, F El Rassi, M McLemore	01/01/2022
Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY). American journal of hematology	I Osunkwo, B Andemariam, CP Minniti, BPD Inusa, F El Rassi, B Francis-Gibson, A Nero, C Trimnell, MR Abboud, JB Arlet, R Colombatti, M de Montalembert, S Jain, W Jastaniah, E Nur, M Pita, L DeBonnett, N Ramscar, T Bailey, O Rajkovic-Hooley, J James	04/01/2021
Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors. Journal of clinical medicine	JH Kong, EF Winton, LT Heffner, M Gaddh, B Hill, J Neely, A Hatcher, M Joseph, M Arellano, F El-Rassi, A Kim, JH Khoury, VK Kota	05/20/2020
Challenges in the treatment and prevention of delayed hemolytic transfusion reactions with hyperhemolysis in sickle cell disease patients. Transfusion	CL Dean, CL Maier, S Chonat, A Chang, MA Carden, F El Rassi, ML McLemore, SR Stowell, RM Fasano	05/01/2019
Extreme hyperbilirubinemia: An indicator of morbidity and mortality in sickle cell disease. World journal of hepatology	JP Haydek, C Taborda, R Shah, PA Reshamwala, ML McLemore, FE Rassi, S Chawla	03/27/2019
Iron overload in patients with myelodysplastic syndromes: An updated overview. Cancer	NM Moukalled, FA El Rassi, SN Temraz, AT Taher	10/15/2018

Awards

Honors, American University of Beirut Medical School, 2004
Nominated for the Penrose Award, American University of Beirut Medical School, 2006
Excellence in Student Teaching Award, Saint Louis University Hospital, Saint Louis, MO, 2011
Doctors’ Day Recognition honoree, Emory University School of Medicine, 2019, 2022, 2023
Researcher Appreciation Day honoree, Emory University School of Medicine, 2025

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.